Dalbavancin
NDC 71839-144, dalbavancin, injection, powder, lyophilized, for solution, from BE Pharmaceuticals Inc..
- Product NDC
- 71839-144
- Status
- Listed
- Labeler
- BE Pharmaceuticals Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219604
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71839-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DALBAVANCIN HYDROCHLORIDE500 mg/25mL
Pharmacologic classes
Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71839-144-01 | 71839014401 | 1 VIAL in 1 CARTON (71839-144-01) / 25 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6c188995-ab05-45c3-a3af-5b1bcd655fdc
Use it
Look up 71839-144 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71839-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71839-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.